Publications

Frères P, Bouznad N, Servais L, Josse C, Wenric S, Poncin A, Thiry J, Moonen M, Oury C, Lancellotti P, Bours V, Jerusalem G. Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients. BMC Cancer; 2018 ;18(1):102. doi:10.1186/s12885-018-4015-4 PMID: 29378531       

Latgé G, Poulet C, Bours V, Josse C, Jerusalem G. Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers. Int J Mol Sci. 2018 Jan 2;19(1):123. doi:10.3390/ijms19010123 PMID: 29301303       

Onesti CE, Josse C, Poncin A, Frères P, Poulet C, Bours V, Jerusalem G. Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment. Oncotarget. 2018 Sep 14;9(72):33719–33733. doi:10.18632/oncotarget.26120  PMID: 30263098 

Goffart N, Lombard A, Lallemand F, Kroonen J, Nassen J, Di Valentin E, Berendsen S, Dedobbeleer M, Willems E, Robe P, Bours V, Martin D, Martinive P, Maquet P, Rogister B. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro Oncol. 2017 Jan;19(1):66–77. doi:10.1093/neuonc/now136       PMID: 27370398       

Wenric S*, Sticca T*, Caberg J-H, Josse C, Fasquelle C, Herens C, Jamar M, Max S, Gothot A, Caers J, Bours V. Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample. Genet Epidemiol. 2017 Jan 10;41(1):35–40. PMID: 27862228

Sticca T, Caberg J-H, Wenric S, Poulet C, Herens C, Jamar M, Josse C, El Guendi S, Max S, Beguin Y, Gothot A, Caers J, Bours V. Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexity. Genes Chromosomes Cancer. 2017 Jan 25;56(1):18–27. doi:10.1002/gcc.22397 PMID: 27454822       

Wenric S*, ElGuendi S*, Caberg J-H, Bezzaou W, Fasquelle C, Charloteaux B, Karim L, Hennuy B, Frères P, Collignon J, Boukerroucha M, Schroeder H, Olivier F, Jossa V, Jerusalem G#, Josse C#, Bours V#. Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Sci Rep. 2017 Dec 12;7(1):17452. doi:10.1038/s41598-017-17811-2 PMID: 29234122      

Frères P*, Wenric S*, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V#, Josse C#, Jerusalem G#. Circulating microRNA-based screening tool for breast cancer. Oncotarget. 2016 Feb 2;7(5):5416–28. doi:10.18632/oncotarget.6786 PMID: 26734993       

Berendsen S, Varkila M, Kroonen J, Seute T, Snijders TJ, Kauw F, Spliet WGM, Willems M, Poulet C, Broekman ML, Bours V, Robe PA. Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro Oncol. 2016 May;18(5):700–6. doi:10.1093/neuonc/nov238 PMID: 26420896       

Dubois N*, Willems M*, Nguyen-Khac M-T, Kroonen J, Goffart N, Deprez M, Bours V, Robe PA. Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential. Int J Oncol. 2016 Jun;48(6):2445–52. doi:10.3892/ijo.2016.3490 PMID: 27098015       

Willems M, Dubois N, Musumeci L, Bours V, Robe PA. IκBζ: an emerging player in cancer. Oncotarget. 2016;7(40):66310–66322. doi:10.18632/oncotarget.11624 PMID: 27579619      

Boukerroucha M, Josse C, Segers K, El-Guendi S, Frères P, Jerusalem G, Bours V. BRCA1 germline mutation and glioblastoma development: report of cases. BMC Cancer. 2015 Dec 26;15(1):181. doi:10.1186/s12885-015-1205-1 PMID: 25880076       

Boukerroucha M*, Josse C*, ElGuendi S, Boujemla B, Frères P, Marée R, Wenric S, Segers K, Collignon J, Jerusalem G, Bours V. Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers. BMC Cancer. 2015 Dec;15(1):755. doi:10.1186/s12885-015-1740-9 PMID: 26490435       

Artesi M, Kroonen J, Bredel M, Nguyen-Khac M, Deprez M, Schoysman L, Poulet C, Chakravarti A, Kim H, Scholtens D, Seute T, Rogister B, Bours V, Robe PA. Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.Neuro Oncol. 2015 Mar 25;17(3):392–406. doi:10.1093/neuonc/nou215 PMID: 25155356       

Frères P, Josse C, Bovy N, Boukerroucha M, Struman I, Bours V, Jerusalem G. Neoadjuvant chemotherapy in breast cancer patients induces miR-34a and miR-122 expression. J Cell Physiol. 2015 Feb;230(2):473–481. doi:10.1002/jcp.24730 PMID: 25078559       

Bovy N, Blomme B, Frères P, Dederen S, Nivelles O, Lion M, Carnet O, Martial JA, Noël A, Thiry M, Jérusalem G, Josse C, Bours V, Tabruyn SP, Struman I. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. 2015 Apr 30;6(12):10253–66. ,doi:10.18632/oncotarget.3520PMID: 25860935